中国女性心血管疾病预防专家共识

2017-06-30 中国医师协会心血管内科医师分会 中华内科杂志.2017,56(6):472-476.

心血管疾病(CVD)是威胁我国女性健康的头号杀手,尚未得到足够重视。中国女性占全世界35亿女性总数的1/5,健康促进和慢病防控工作面临严峻挑战。女性CVD 的病理生理学特点、临床表现、疾病诊断、药物代谢和防治策略在有些方面有别于男性,需要特别关注。中国医师协会心血管内科医师分会女医师工作委员会和中华医学会心血管病学分会女性心脏健康学组组织相关专家制定“中国女性心血管疾病预防专家共识”,旨在加强并推

中文标题:

中国女性心血管疾病预防专家共识

发布日期:

2017-06-30

简要介绍:

心血管疾病(CVD)是威胁我国女性健康的头号杀手,尚未得到足够重视。中国女性占全世界35亿女性总数的1/5,健康促进和慢病防控工作面临严峻挑战。女性CVD 的病理生理学特点、临床表现、疾病诊断、药物代谢和防治策略在有些方面有别于男性,需要特别关注。中国医师协会心血管内科医师分会女医师工作委员会和中华医学会心血管病学分会女性心脏健康学组组织相关专家制定“中国女性心血管疾病预防专家共识”,旨在加强并推动我国女性CVD的防控工作。

 

拓展指南:心血管相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=中国女性心血管疾病预防专家共识)] GetToolGuiderByIdResponse(projectId=1, id=c479e1c001ae008d, title=中国女性心血管疾病预防专家共识, enTitle=, guiderFrom=中华内科杂志.2017,56(6):472-476., authorId=null, author=, summary=心血管疾病(CVD)是威胁我国女性健康的头号杀手,尚未得到足够重视。中国女性占全世界35亿女性总数的1/5,健康促进和慢病防控工作面临严峻挑战。女性CVD 的病理生理学特点、临床表现、疾病诊断、药物代谢和防治策略在有些方面有别于男性,需要特别关注。中国医师协会心血管内科医师分会女医师工作委员会和中华医学会心血管病学分会女性心脏健康学组组织相关专家制定“中国女性心血管疾病预防专家共识”,旨在加强并推, cover=, journalId=null, articlesId=null, associationId=315, associationName=中国医师协会心血管内科医师分会, associationIntro=null, copyright=0, guiderPublishedTime=Fri Jun 30 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>心血管疾病(CVD)是威胁我国女性健康的头号杀手,尚未得到足够重视。中国女性占全世界35亿女性总数的1/5,健康促进和慢病防控工作面临严峻挑战。女性CVD 的病理生理学特点、临床表现、疾病诊断、药物代谢和防治策略在有些方面有别于男性,需要特别关注。中国医师协会心血管内科医师分会女医师工作委员会和中华医学会心血管病学分会女性心脏健康学组组织相关专家制定“中国女性心血管疾病预防专家共识”,旨在加强并推动我国女性CVD的防控工作。</P> <P> </P>拓展指南:<strong>与<font color=red>心血管</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=d34af1c001a69460" title="《心血管疾病合并失眠诊疗中国专家共识》(2017)简读" target=_blank>《心血管疾病合并失眠诊疗中国专家共识》(2017)简读</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=5005e1c001a693c3" title="心血管疾病合并失眠诊疗中国专家共识" target=_blank>心血管疾病合并失眠诊疗中国专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=07fcf1c001a668d7" title="2型糖尿病合并动脉粥样硬化性心血管疾病患者降糖药物应用专家共识" target=_blank>2型糖尿病合并动脉粥样硬化性心血管疾病患者降糖药物应用专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=6895c1c001a5438c" title="2016 马来西亚女性心血管疾病预防指南(第2版)" target=_blank>2016 马来西亚女性心血管疾病预防指南(第2版)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=d9ca61c001a53352" title="中国心血管疾病临床病理标本处理与检测规范" target=_blank>中国心血管疾病临床病理标本处理与检测规范</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E5%BF%83%E8%A1%80%E7%AE%A1" target=_blank>有关心血管更多指南</a></ul>, tagList=[TagDto(tagId=986, tagName=女性), TagDto(tagId=2529, tagName=心血管疾病)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5071, appHits=216, showAppHits=0, pcHits=3763, showPcHits=1532, likes=121, shares=9, comments=4, approvalStatus=1, publishedTime=Mon Jul 17 22:56:34 CST 2017, publishedTimeString=2017-06-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Mon Jul 17 22:56:34 CST 2017, updatedBy=null, updatedName=null, updatedTime=Wed Jan 03 21:29:10 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=中国女性心血管疾病预防专家共识)])
中国女性心血管疾病预防专家共识
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=225897, encodeId=5ea522589ec2, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Mon Jul 24 20:30:15 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223880, encodeId=c44c22388088, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Wed Jul 19 11:26:20 CST 2017, time=2017-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223876, encodeId=75d02238e61e, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Wed Jul 19 11:24:58 CST 2017, time=2017-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223817, encodeId=d89a22381eab, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Wed Jul 19 08:29:30 CST 2017, time=2017-07-19, status=1, ipAttribution=)]
    2017-07-24 wxl882001

    学习一下

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=225897, encodeId=5ea522589ec2, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Mon Jul 24 20:30:15 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223880, encodeId=c44c22388088, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Wed Jul 19 11:26:20 CST 2017, time=2017-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223876, encodeId=75d02238e61e, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Wed Jul 19 11:24:58 CST 2017, time=2017-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223817, encodeId=d89a22381eab, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Wed Jul 19 08:29:30 CST 2017, time=2017-07-19, status=1, ipAttribution=)]
    2017-07-19 Y—xianghai

    学习了新知识

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=225897, encodeId=5ea522589ec2, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Mon Jul 24 20:30:15 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223880, encodeId=c44c22388088, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Wed Jul 19 11:26:20 CST 2017, time=2017-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223876, encodeId=75d02238e61e, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Wed Jul 19 11:24:58 CST 2017, time=2017-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223817, encodeId=d89a22381eab, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Wed Jul 19 08:29:30 CST 2017, time=2017-07-19, status=1, ipAttribution=)]
    2017-07-19 Y—xianghai

    学习了新知识

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=225897, encodeId=5ea522589ec2, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Mon Jul 24 20:30:15 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223880, encodeId=c44c22388088, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Wed Jul 19 11:26:20 CST 2017, time=2017-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223876, encodeId=75d02238e61e, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Wed Jul 19 11:24:58 CST 2017, time=2017-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223817, encodeId=d89a22381eab, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Wed Jul 19 08:29:30 CST 2017, time=2017-07-19, status=1, ipAttribution=)]
    2017-07-19 1e0ece0dm09(暂无匿称)

    谢谢分享

    0